Breaking: Trump Accelerates Marijuana Reclassification to Schedule III in 2024

President Trump signs executive order to fast-track marijuana's move from Schedule I to Schedule III, aiming to boost medical research and ease industry burdens.

Breaking News: Trump Orders Faster Marijuana Reclassification

US President Donald Trump has signed an executive order on Thursday, March 2024, instructing the speedy reclassification of marijuana from Schedule I to Schedule III. This move aims to promote medical research and reshape federal policy around cannabis. Key details on implications and what this means for businesses follow.

• Key Takeaways:
• Marijuana reclassification process accelerated by executive order
• Medical research and cannabis industry potentially boosted
• Does not legalize marijuana federally
• Potential tax relief for cannabis companies

Executive Order Aims to Boost Research

The Trump administration's order directs US Attorney General Pam Bondi to expedite marijuana's reclassification. The prior Biden administration initiated this but faced bureaucratic delays.

"The Federal Government’s long delay in recognizing the medical use of marijuana does not serve Americans who report health benefits," the order states.

• Marijuana currently Schedule I with heroin and LSD
• Schedule III drugs have lower abuse potential and accepted medical use

What’s your take on accelerating cannabis research?

What the Reclassification Means Legally

Crucially, this order does not legalize marijuana federally or sanction recreational use.

Trump emphasized, "This is not the legalization of marijuana in any way, shape or form."

• 40 states allow medical marijuana use
• 24 states have legalized recreational use
• Federal Controlled Substances Act still classifies marijuana as illegal

Do you think federal legalization will follow this reclassification?

Industry Impact: Tax Relief and Growth

Reclassification would remove cannabis companies from IRS Code 280E restrictions, letting them deduct routine business expenses and potentially saving billions annually.

An estimate from Viridian Capital Advisors suggests top 12 cannabis firms could save $800 million yearly.

• Potential drop in retail cannabis prices
• Easier access to funding and insurance coverage prospects
• FDA approval for new cannabis medicines could increase

How might this shift affect the cannabis market you know?

What Comes Next

The executive order sets a policy tone, but reclassification requires regulatory and legislative steps ahead.

• Timeline for official DEA reclassification unknown
• Continued debate over federal marijuana legalization ongoing
• Medical community anticipates more research opportunities

Stay tuned as developments unfold in this pivotal cannabis policy shift.

What We Know

1. President Trump signed executive order on March 2024
2. Marijuana to be reclassified from Schedule I to Schedule III
3. Does not legalize recreational marijuana federally
4. Industry poised for major tax reform benefits
5. Research on cannabis use expected to expand

What do you think about these changes? Share your thoughts.